🇰🇷 South Korea Country × Condition
ovarian cancer Clinical Trials in South Korea
Active clinical trials for ovarian cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT07069335 Phase 1
Recruiting
A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer
Enrollment
24 pts
Country
🇰🇷 South Korea
Boryung Pharmaceutical Co., Ltd
View Trial → NCT07059845 Phase 2
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Enrollment
320 pts
Country
🇰🇷 South Korea
AbbVie
View Trial → Frequently Asked Questions
How many ovarian cancer clinical trials are active in South Korea?
There are currently 2 active clinical trials for ovarian cancer with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a ovarian cancer clinical trial in South Korea?
To join a ovarian cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer trials in South Korea?
Active ovarian cancer trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.